January 13, 2006

SpeculatingStocks.com Stock Pick: Elan Corporation (ELN)

Stock Price: $16.05 (long-term strong buy)

We first released ELN as a stock pick on March 9th of last year at $7.88. Now with its strong uptrend, we believe it is worthy of another recommendation after reaching our 6-12 month target.

Elan Corporation is a neuroscience-based biotechnology company engaged in discovering, developing, manufacturing and marketing therapies in autoimmune diseases, including pain and neurodegenerative diseases.

Elan is a 6.82 billion dollar biotech operation. The company has over $1.5 billion in cash on the balance sheet to support operations. People are still shy to short this stock too much, currently, 7.21% of the stock is being shorted.

As we said, the trend is up and it doesn't seem like any thing is slowing this company down.

SpeculatingStocks.com Target Price: We expect ELN to reach $25 within the next 3 - 6 months.